Andreas Halvorsen's position in Adaptive Biotechnologies is currently worth $108 Million. That's 0.41% of their equity portfolio (51st largest holding). The investor owns 19.75% of the outstanding Adaptive Biotechnologies stock. Andreas Halvorsen started to build up the position in Adaptive Biotechnologies in Q2 2019 and continued to invest until Q2 2019. Since then they sold 8.41 Million shares. The investor's estimated purchase price is $1.33 Billion, resulting in a loss of 92%.